Related Links Educational Materials About Clinical Trials Clinical Trials Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Phase II Study of Allogeneic Umbilical Cord and Placental Blood Transplantation in Patients With Chronic Myeloid Leukemia, Acute Leukemia, Lymphoma, Myeloma, Myelodysplasia, Aplastic Anemia, Fanconi's Anemia, Histiocytosis, Hereditary Immunodeficiency, or Storage Disorder

Basic Trial Information

Phase	Type	Status	Age	Sponsor	Protocol IDs
Phase II	Treatment	Closed	Under physiologic 60	NCI	CPMC-IRB-7934 CPMC-CAMP-021, NCI-G00-1899, NCT00008164

Trial Description

Purpose:

Umbilical cord blood or placental blood transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy that was used to kill cancer cells.

Phase II trial to study the effectiveness of umbilical cord blood and placental blood transplantation in treating patients who have hematologic cancer or aplastic anemia.

Eligibility:

Eligibility criteria include the following:

• Younger than 60 years old
• No bone marrow donor available
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will receive chemotherapy and/or radiation therapy followed by umbilical cord blood. Patients will receive follow-up evaluations every 1-2 weeks for 6 months.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center

David Savage, MD, Protocol chair		Ph: 212-305-9783

Registry Information
Official Title		Transplantation Using Umbilical Cord And Placental Blood
Trial Start Date		1997-01-29
Registered in ClinicalTrials.gov		NCT00008164
Date Submitted to PDQ		2000-11-16
Information Last Verified		2007-01-15
NCI Grant/Contract Number		CA13696

Back to Top